Marshall Wace’s 2seventy bio TSVT Stock Holding History

Marshall Wace’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,028	Closed	-$98.9K	–	3190
2025 Q1	$98.9K	Sell	20,028 -255,508	-93%	-$812K	﹤0.01%	2498
2024 Q4	$810K	Sell	275,536 -193,347	-41%	-$793K	﹤0.01%	1828
2024 Q3	$2.21M	Sell	468,883 -198,140	-30%	-$894K	﹤0.01%	1330
2024 Q2	$2.57M	Buy	667,023 +223,408	+50%	+$1.01M	﹤0.01%	1251
2024 Q1	$2.37M	Sell	443,615 -666,404	-60%	-$3.13M	﹤0.01%	1281
2023 Q4	$4.74M	Buy	+1,110,019	New	+$3.41M	0.01%	933
2023 Q2	–	Sell	-65,558	Closed	-$669K	–	2973
2023 Q1	$669K	Buy	+65,558	New	+$750K	﹤0.01%	1984

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Marshall Wace's TSVT Position: Q2 2025 in Review

Marshall Wace sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 20,028 shares — an estimated $98.9K sold.

Marshall Wace first reported a position in TSVT in Q1 2023 and held it in 7 quarters. The position peaked at $4.74M in Q4 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Marshall Wace reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Marshall Wace sold 20,028 2seventy bio shares in Q2 2025, an estimated $98.9K.
Marshall Wace first reported a position in 2seventy bio in Q1 2023 and held it in 7 quarters.
Marshall Wace's 2seventy bio position peaked at $4.74M in Q4 2023.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.